P53 as a prognostic marker for bladder cancer: a meta-analysis and review
- 1 September 2005
- journal article
- research article
- Published by Elsevier BV in The Lancet Oncology
- Vol. 6 (9), 678-686
- https://doi.org/10.1016/s1470-2045(05)70315-6
Abstract
No abstract availableKeywords
This publication has 60 references indexed in Scilit:
- p53 and RB: Simple Interesting Correlates or Tumor Markers of Critical Predictive Nature?Journal of Clinical Oncology, 2004
- Ki‐67 index enhances the prognostic accuracy of the urothelial superficial bladder carcinoma risk group classificationInternational Journal of Cancer, 2003
- Patterns of multiple recurrences of superficial (Ta/T1) transitional cell carcinoma of bladder and effects of clinicopathologic and biochemical factorsCancer, 2002
- Assessing TP53 status in human tumours to evaluate clinical outcomeNature Reviews Cancer, 2001
- p53 NUCLEAR ACCUMULATION IS NOT ASSOCIATED WITH DECREASED DISEASE-FREE SURVIVAL IN PATIENTS WITH NODE POSITIVE TRANSITIONAL CELL CARCINOMA OF THE BLADDERJournal of Urology, 2000
- Prognostic value of the expression of E-cadherin and β-catenin in bladder cancerEuropean Journal Of Cancer, 2000
- p53 Immunohistochemistry as a Prognostic Marker in Bladder CancerEuropean Urology, 2000
- Can p53 nuclear over-expression, Bcl-2 accumulation and PCNA status be of prognostic significance in high-risk superficial and invasive bladder tumours?European Journal of Surgical Oncology, 1999
- Overexpression of p53 protein and its significance for recurrent progressive bladder tumoursBritish Journal of Urology, 1996
- Dangers of Using "Optimal" Cutpoints in the Evaluation of Prognostic FactorsJNCI Journal of the National Cancer Institute, 1994